Postdoctoral Fellow - AI/ML Upstream Cell Culture Modeling & Process Development
Eli Lilly and Company
Summary
The Upstream Process Development group within our BR&D organization is seeking a Postdoctoral Fellow to join a team of scientists and engineers focused on developing and optimizing mammalian cell culture processes for recombinant proteins and other modalities for early- and late-phase clinical trials.
Job description
Position Summary
The Upstream Process Development group within our BR&D organization is seeking a Postdoctoral Fellow to join a team of scientists and engineers focused on developing and optimizing mammalian cell culture processes for recombinant proteins and other modalities for early- and late-phase clinical trials.
This role will focus on developing and applying innovative mathematical and computational modeling approaches to characterize, understand, and predict the complex biological systems used in mammalian cell culture. The fellow will build mechanistic and data-driven models, including genome-scale and hybrid metabolic models, to predict cellular behavior, diagnose process bottlenecks, and rationally guide the design of feeding strategies and medium compositions. Where current development often relies on iterative empirical screening, this position aims to establish a model-guided approach that narrows the experimental search space before committing significant laboratory effort.
The fellow will also explore the use of these models within real-time monitoring and control frameworks, and will leverage machine learning to enable earlier, model-informed decisions such as clone selection based on predicted process performance. The work establishes a closed-loop cycle in which model predictions are validated experimentally and the resulting data continuously improves model accuracy. This position is well suited to a highly motivated scientist who wants to bridge computational modeling and hands-on bioprocess experimentation.
Responsibilities
- Develop and calibrate mechanistic and hybrid metabolic models of mammalian cell culture processes, integrating process data to predict cellular behavior and identify performance-limiting factors.
- Build computational pipelines that turn routine bioprocess data into model inputs and generate predicted metabolic flux distributions across the culture cycle.
- Apply machine learning and data-driven methods for performance prediction and to integrate model-derived features with experimental data.
- Use calibrated models to evaluate feeding strategies and medium compositions to enhance productivity.
- Design and execute cell culture experiments—from shake flask to bench-scale bioreactors—to generate datasets for model development, training, and validation.
- Collaborate with the Analytical team to develop multi-omics methods for metabolic model calibration.
- Integrate model-derived features into machine learning workflows to support earlier decisions, including predictive clone selection from earlier-stage process data.
- Investigate AI-assisted approaches to accelerate model building, validation, and reuse across projects, with human-in-the-loop decision support.
- Maintain rigorous documentation, communicate results through technical reports, presentations, and peer-reviewed publications, and collaborate across cross-functional teams.
Basic Requirements
- PhD in Chemical/Biochemical Engineering, Bioengineering, Systems Biology, Computational Biology, Metabolic Engineering, or a related field.
- Experience with constraint-based or genome-scale metabolic modeling.
- Hands-on experience designing and executing cell culture experiments with a working understanding of Batch, Fed-batch, and Intensified Processes.
- Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization or visas for this role, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1.
Additional Preferences
- Strong foundation in mathematical modeling, reaction kinetics, and mammalian cell culture.
- Proficiency in Python, MATLAB, or similar scientific programming languages.
- Familiarity with process control concepts, including model predictive control or dynamic optimization.
- Understanding of mammalian (e.g., CHO) cell physiology and metabolism relevant to bioprocessing.
- Experience with analytical methods such as HPLC, UPLC, and mass spectrometry is a plus.
- Experience integrating omics data with mechanistic or hybrid models.
- Demonstrated expertise in machine learning and data-driven modeling is a plus.
Requirements
- PhD in Chemical/Biochemical Engineering, Bioengineering, Systems Biology, Computational Biology, Metabolic Engineering, or a related field
- Experience with constraint-based or genome-scale metabolic modeling
- Hands-on experience designing and executing cell culture experiments
- Working understanding of Batch, Fed-batch, and Intensified Processes
- Authorized to work in the United States on a full-time basis
- Strong foundation in mathematical modeling, reaction kinetics, and mammalian cell culture
- Proficiency in Python, MATLAB, or similar scientific programming languages
- Familiarity with process control concepts, including model predictive control or dynamic optimization
- Understanding of mammalian (e.g., CHO) cell physiology and metabolism relevant to bioprocessing
- Experience with analytical methods such as HPLC, UPLC, and mass spectrometry is a plus
- Experience integrating omics data with mechanistic or hybrid models
- Demonstrated expertise in machine learning and data-driven modeling is a plus
Benefits
- Company Bonus
- 401(k)
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Leave Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs and Activities
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.